Image 2_Serum creatinine-to-cystatin C ratio and 1-year mortality risk in advanced breast cancer patients: a multicenter retrospective cohort study.tif

Image 2_Serum creatinine-to-cystatin C ratio and 1-year mortality risk in advanced breast cancer patients: a multicenter retrospective cohort study.tif

Background<p>Muscle wasting and sarcopenia in advanced breast cancer correlates with poor outcomes. The serum creatinine-to-cystatin C ratio (CCR) is a potential muscle mass biomarker, but its prognostic value in advanced breast cancer is unclear.</p>Methods<p>This multicenter retr...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
1. autor: Huijie Deng (5664421) (author)
Kolejni autorzy: Jiacheng Yang (4867897) (author), Guanyu Zheng (602277) (author), Biyao Zhang (3160059) (author), Yuzhou Wang (600730) (author), Yuye Wu (22381971) (author), Shufen Mo (21743543) (author), Shengchao Huang (22686392) (author), Yuanqi Zhang (18483375) (author), Lixia Li (407712) (author)
Wydane: 2025
Hasła przedmiotowe:
Clinical and Sports Nutrition
breast cancer
creatinine
cystatin C
creatinine–cystatin C
muscle mass
sarcopenia
mortality
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
Napisz pierwszy komentarz!
Najpierw się zaloguj

Podobne zapisy